What is the size of Genetic Testing Market?
According to 6Wresearch internal database and industry insights, the
Global Genetic Testing Market was demonstrated around USD 18 billion in 2024 and is projected to be USD 44 billion by 2031, expanding at a CAGR of 13.7% during the forecast period 2025-2031.
The genetic testing market is continued to expand its landscape, as the market is driven by the increasing adoption of personalized medicine, early disease detection strategies, and rising awareness of genetic disorders.
Key Growth Factors of the Genetic Testing Market
- Surging demand for the predictive and preventive healthcare solutions
- Increasing prevalence of hereditary and rare genetic diseases
- Advancements in next-generation sequencing and molecular diagnostics
- Rising consumer interest in ancestry and direct-to-consumer tests
- Supports of government through initiatives genomics-based screening programs
- Expanding applications in oncology, pharmacogenomics, and reproductive health
Genetic Testing Market Trends
In the coming years, the market is moving forward with the factors including non-invasive prenatal testing (NIPT), carrier screening, and tumour profiling. Direct-to-consumer genetic test kits are becoming more affordable and accessible. Integration of AI in genetic data analysis and interpretation is transforming diagnostic efficiency. Further, the healthcare systems are also increasingly integrating genomics into electronic health records (EHRs) to support personalized treatment.
Emerging Developments in the Genetic Testing Market
CRISPR-based diagnostics, point-of-care DNA testing platforms, and AI-powered risk prediction tools are few emerging developments noticed in the Genetic Testing Market. The focus of company is rising on the rapid turnaround time, privacy-compliant data storage, and multi-gene panel testing. Business strategies such as the collaborations between pharmaceutical firms and genomics companies are also advancing targeted therapy research and biomarker discovery.
Major Companies in the Genetic Testing Market
- 23andMe
- Illumina
- Myriad Genetics
- Thermo Fisher Scientific
- Invitae
- Fulgent Genetics
- Color Genomics
- Roche Diagnostics
- Qiagen
Genetic Testing Market Size : FAQ's
The size of genetic testing market was exhibited at USD 18 billion in 2024 and is projected to reach USD 44 billion by 2031.
The major drivers are wider accessibility, falling costs of sequencing, and growing interest in predictive and preventive care.
North America leads due to advanced healthcare infrastructure, while Asia-Pacific is rapidly growing.
It enables early detection, identifies risk genes (like BRCA), and guides treatment through targeted therapy selection.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com